Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis

American Journal of Clinical Nutrition

Volumn 101, Issue 1, 2015, Pages 34-43

  Lee, Joseph J ^a   Lambert, Jennifer E ^a   Hovhannisyan, Yelena ^a   Ramos Roman, Maria A ^b   Trombold, Justin R ^a   Wagner, David A ^c   Parks, Elizabeth J ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c METABOLIC SOLUTIONS INC   (United States)

^d University of Missouri   (United States)

Author keywords

Biomarker; Lipogenesis; Palmitoleic fatty acid; Stearoyl CoA desaturase; VLDL triacylglycerol

Indexed keywords

FATTY ACID; INSULIN; PALMITOLEIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ACYL COENZYME A DESATURASE; BIOLOGICAL MARKER; DEUTERIUM OXIDE; MONOUNSATURATED FATTY ACID; PALMITIC ACID; SCD1 PROTEIN, HUMAN; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

ADULT; ARTICLE; COMBUSTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DE NOVO LIPOGENESIS; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID DESATURATION; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOGENESIS; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; POPULATION RESEARCH; ALGORITHM; BLOOD; BODY MASS; CLINICAL TRIAL; DIET THERAPY; ENZYMOLOGY; LIVER; LOW FAT DIET; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOPHYSIOLOGY; UPREGULATION;

ADIPOSITY; ADULT; ALGORITHMS; BIOMARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DEUTERIUM OXIDE; DIET, FAT-RESTRICTED; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOGENESIS; LIPOPROTEINS, VLDL; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OVERWEIGHT; PALMITIC ACID; STEAROYL-COA DESATURASE; TRIGLYCERIDES; UP-REGULATION;

EID: 84919626918     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.092262     Document Type: Article

References (59)

1. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-51.
2. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 2003;29:478-85.
3. Schwarz J-M, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003;77:43-50.
4. Wilke MS, French MA, Goh YK, Ryan EA, Jones PJ, Clandinin MT. Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia 2009;52:1628-37.
5. Vedala A, Wang W, Neese RA, Christiansen MP, Hellerstein MK. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J Lipid Res 2006;47:2562-74.
6. Marques-Lopes I, Ansorena D, Astiasaran I, Forga L, Martínez JA. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am J Clin Nutr 2001;73:253-61.
7. Aarsland A, Wolfe RR. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res 1998;39:1280-6.
8. Field CJ, Ryan EA, Thomson AB, Clandinin MT. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 1990;265:11143-50.
9. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 1996;97:2081-91.
10. Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, Hirsch J. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res 2000;41: 595-604.
11. Hudgins LC, Parker TS, Levine DM, Hellerstein MK. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J Clin Endocrinol Metab 2011;96:861-8.
12. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348-80.
13. Durrington PN, Bolton CH, Hartog M, Angelinetta R, Emmett P, Furniss S. The effect of a low-cholesterol, high-polyunsaturate diet on serum lipid levels, apolipoprotein B levels and triglyceride fatty acid composition. Atherosclerosis 1977;27:465-75.
14. Emken EA. Metabolism of dietary stearic acid relative to other fatty acids in human subjects. Am J Clin Nutr 1994;60:1023S-8S.
15. Sjögren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius M-L, Fisher RM. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia 2008;51:328-35.
16. Gong J, Campos H, McGarvey S, Wu Z, Goldberg R, Baylin A. Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine? Am J Clin Nutr 2011;93:186-91.
17. de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr 2002;21:219-23.
18. Chong MF-F, Hodson L, Bickerton AS, Roberts R, Neville M, Karpe F, Frayn KN, Fielding BA. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am J Clin Nutr 2008;87:817-23.
19. Fabbrini E, Magkos F, Su X, Abumrad NA, Nejedly N, Coughlin CC, Okunade AL, Patterson BW, Klein S. Insulin sensitivity is not associated with palmitoleate availability in obese humans. J Lipid Res 2011;52:808-12.
20. Forsythe CE, Phinney SD, Feinman RD, Volk BM, Freidenreich D, Quann E, Ballard K, Puglisi MJ, Maresh CM, Kraemer WJ, et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 2010;45:947-62.
21. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004;41:41-78.
22. Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, RuskeepääA-L, Oresic M, Yki-Järvinen H. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 2009;58:203-8.
23. Klein-Platat C, Drai J, Oujaa M, Schlienger J-L, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and lowgrade inflammation in overweight adolescents. Am J Clin Nutr 2005; 82:1178-84.
24. KunesováM, Hainer V, Tvrzicka E, Phinney SD, Stich V, ParízkováJ, Zák A, Stunkard AJ. Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids 2002;37:27-32.
25. WarensjöE, Rosell M, Hellenius M-L, Vessby B, De Faire U, Risé rus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis 2009;8:37.
26. Paillard F, Catheline D, Le Duff F, Bouriel M, Deugnier Y, Pouchard M, Daubert J-C, Legrand P. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 2008; 18:436-40.
27. Vessby B, Ahré n B, WarensjöE, Lindgärde F. Plasma lipid fatty acid composition, desaturase activities and insulin sensitivity in Amerindian women. Nutr Metab Cardiovasc Dis 2012;22:176-81.
28. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AFH, Stoehr JP, Hayden MR, et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 2002;43:1899-907.
29. Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 2014;146:726-35.
30. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006;21:1-6.
31. Turner SM, Murphy EJ, Neese RA, Antelo F, Thomas T, Agarwal A, Go C, Hellerstein MK. Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA. Am J Physiol Endocrinol Metab 2003;285:E790-803.
32. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288: E462-8.
33. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95.
34. Crouter SE, Dellavalle DM, Horton M, Haas JD, Frongillo EA, Bassett DR. Validity of the Actical for estimating free-living physical activity. Eur J Appl Physiol 2011;111:1381-9.
35. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab 2006;91:1446-52.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
37. Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, Darland C, Finch J, Gastaldelli A, Harrison S, Tio F, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2012;55: 1389-97.
38. Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Königsrainer A, Königsrainer I, Häring H-U, Schleicher E. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem 2009;55:2113-20.
39. Timlin MT, Barrows BR, Parks EJ. Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men. Diabetes 2005;54: 2694-701.
40. Murphy EJ. Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism. J Anim Sci 2006;84:E94-104.
41. Brenna JT. Use of stable isotopes to study fatty acid and lipoprotein metabolism in man. Prostaglandins Leukot Essent Fatty Acids 1997; 57:467-72.
42. Peter A, Cegan A, Wagner S, Elcnerova M, Königsrainer A, Königsrainer I, Häring H-U, Schleicher ED, Stefan N. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. Am J Physiol Endocrinol Metab 2011;300:E321-6.
43. Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 2009;50: 1087-93.
44. Peter A, Weigert C, Staiger H, Machicao F, Schick F, Machann J, Stefan N, Thamer C, Häring H-U, Schleicher E. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 2009;58: 1757-65.
45. Silbernagel G, Kovarova M, Cegan A, Machann J, Schick F, Lehmann R, Häring H-U, Stefan N, Schleicher E, Fritsche A, et al. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J Clin Endocrinol Metab 2012;97:E2288-92.
46. Hodson L, Karpe F. Is there something special about palmitoleate? Curr Opin Clin Nutr Metab Care 2013;16:225-31.
47. Benhamed F, Denechaud P-D, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, Ratziu V, Serfaty L, Housset C, Capeau J, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest 2012;122: 2176-94.
48. Roberts R, Hodson L, Dennis AL, Neville MJ, Humphreys SM, Harnden KE, Micklem KJ, Frayn KN. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009;52:882-90.
49. Sjöström L. Fatty acid synthesis de novo in adipose tissue from obese subjects on a hypercaloric high-carbohydrate diet. Scand J Clin Lab Invest 1973;32:339-49.
50. Hellerstein MK. De novo lipogenesis in humans: metabolic and regulatory aspects. Eur J Clin Nutr 1999;53:S53-65.
51. Strawford A, Antelo F, Christiansen M, Hellerstein MK. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. Am J Physiol Endocrinol Metab 2004; 286:E577-88.
52. Koutsari C, Mundi MS, Ali AH, Patterson BW, Jensen MD. Systemic free fatty acid disposal into very low-density lipoprotein triglycerides. Diabetes 2013;62:2386-95.
53. Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 2009;284:5637-44.
54. Oosterveer MH, van Dijk TH, Tietge UJF, Boer T, Havinga R, Stellaard F, Groen AK, Kuipers F, Reijngoud D-J. High fat feeding induces hepatic fatty acid elongation in mice. PLoS ONE 2009;4:e6066.
55. Collins JM, Neville MJ, Hoppa MB, Frayn KN. De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J Biol Chem 2010;285:6044-52.
56. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077-82.
57. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 2004;106: 635-43.
58. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 2010;92: 1350-8.
59. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 2008;48: 300-7.